IP Library Granted Patent US 8,568,990
Granted Patent B2
US 8,568,990 · App. 13/290,026 · Granted Oct 29, 2013

Methods for identifying compounds that modulate sensory signaling through the taste cell specific G-protein coupled receptor GPCR-B4

Inventors: Charles S. Zuker (San Diego, CA); Jon Elliot Adler (Pacific Beach, CA); Juergen Lindemeier (Werl, DE)
Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,990
App. No.
13/290,026
Granted
Oct 29, 2013
Kind
B2
Abstract

The invention provides isolated nucleic acid and amino acid sequences of sensory cell specific G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of sensory cell specific G-protein coupled receptors.

Claims (14)

1. A method for identifying a compound that modulates sensory signaling in sensory cells, the method comprising the steps of:

(i) contacting the compound with a polypeptide comprising an extracellular domain of a sensory transduction G-protein coupled receptor, the extracellular domain comprising greater than about 90% amino acid sequence identity to the extracellular domain of SEQ ID NO:1 or SEQ ID NO:2; and

(ii) determining the functional effect of the compound upon the extracellular domain.

2. The method of claim 1 , wherein the extracellular domain is linked to a solid phase.

3. The method of claim 1 , wherein the functional effect is a chemical effect.

4. The method of claim 1 , wherein the functional effect is determined by measuring binding of the compound to the extracellular domain.

5. The method of claim 1 , wherein the polypeptide is recombinant.

6. The method of claim 1 , Wherein the polypeptide is from a rat, a mouse, or a human.

7. The method of claim 1 , wherein the polypeptide is expressed in a cell or cell membrane,

8. The method of claim 1 , wherein the functional effect is a physical effect.

9. The method of claim 1 , wherein the extracellular domain of the contacted polypeptide comprises greater than about 90% amino acid sequence identity to the extracellular domain of SEQ ID NO:1.

10. The method of claim 1 , wherein the extracellular domain of the contacted polypeptide comprises greater than about 95% amino acid sequence identity to the extracellular domain of SEQ ID NO:1.

11. The method of claim 1 , wherein the extracellular domain of the contacted polypeptide comprises greater than about 90% amino acid sequence identity to the extracellular domain of SEQ ID NO:2.

12. The method of claim 1 , wherein the extracellular domain of the contacted polypeptide comprises greater than about 95% amino acid sequence identity to the extracellular domain of SEQ ID NO:2.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 23, 2013
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031867/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2013
From: ZUKER, CHARLES S.; ADLER, JON ELLIOT; LINDEMEIER, JUERGEN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030599/0257 →
Continuity (7)
Continuation 12960409 · Dec 3, 2010
Division 11716362 · Mar 8, 2007
Continuation 10096144 · Mar 8, 2002
Continuation 09361631 · Jul 27, 1999
Provisional Application 60095464 · Jul 28, 1998
Provisional Application 60112747 · Dec 17, 1998
Related Publication 20120142029A1 · Jun 7, 2012